What Does Mersana Therapeutics Do?

Total employees158
HeadquartersCambridge
Founded2001

Mersana Therapeutics (NASDAQ: MRSN) is a clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation antibody-drug conjugates (ADCs) for cancer patients. Utilizing its differentiated and proprietary ADC platforms, such as Dolaflexin and Dolasynthen, Mersana aims to create ADCs with optimal efficacy, safety, and tolerability. The company is focused on advancing its pipeline of targeted cancer therapies, driven by a commitment to scientific innovation and a patient-centric approach to address unmet medical needs in oncology.

Where Is Mersana Therapeutics's Headquarters?

HQ Function

Serves as the central hub for Mersana's research and development, clinical operations, corporate strategy, and administrative functions, focusing on advancing its pipeline of antibody-drug conjugates (ADCs).

Notable Features:

State-of-the-art laboratory and research facilities tailored for ADC development and biopharmaceutical innovation. The location is part of a vibrant life sciences campus.

Work Culture:

Characterized by a collaborative, innovative, and patient-focused environment. Employees are driven by scientific excellence, a sense of urgency, and a shared mission to impact the lives of cancer patients. The culture encourages teamwork, open communication, and continuous learning.

HQ Significance:

Strategically located in Cambridge, Massachusetts, a leading global epicenter for biotechnology and pharmaceutical research. This provides access to a rich ecosystem of talent, academic institutions, and potential industry collaborators, fostering innovation and growth.

Values Reflected in HQ: The headquarters' design and functionality reflect Mersana's commitment to cutting-edge science, innovation in ADC technology, and a dynamic, collaborative approach to developing novel cancer therapies.

Location:

While headquartered in Cambridge, MA, USA, Mersana Therapeutics has a global reach primarily through its clinical development activities. The company conducts and plans clinical trials for its ADC candidates in multiple countries, collaborating with international research institutions, clinical sites, and investigators to advance its therapies for cancer patients worldwide. Strategic partnerships and collaborations may further extend its operational and scientific presence globally.

Street Address:

840 Memorial Drive

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Mersana Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Mersana Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Mersana Therapeutics? Meet the Executive Team

As of April 2025, Mersana Therapeutics' leadership includes:

Martin Huber, M.D. - President and Chief Executive Officer
Arvin Yang, M.D., Ph.D. - Executive Vice President and Chief Medical Officer
Brian DeSchuytner - Senior Vice President, Finance and Corporate Strategy
Mohan Bala, Pharm.D. - Senior Vice President and Chief Business Officer
Tushar Misra, Ph.D. - Chief Manufacturing Officer
Tim Lowinger, Ph.D. - Chief Scientific Officer
Carla Poulson - Chief Human Resources Officer

Who's Investing in Mersana Therapeutics?

Mersana Therapeutics has been backed by several prominent investors over the years, including:

Biotechnology Value Fund, L.P.
New Enterprise Associates (NEA)
Fidelity Management & Research Company LLC
Bain Capital Life Sciences
Sarissa Capital Management LP
BlackRock Fund Advisors
The Vanguard Group, Inc.

What Leadership Changes Has Mersana Therapeutics Seen Recently?

Hire2
Exits2

Over the past 12 months, Mersana Therapeutics has experienced key leadership transitions, including the appointment of a new CEO and a new CMO, reflecting a period of strategic refocusing for the company.

Departures

Aleksandra Rizo, M.D., Ph.D., Aleksandra Rizo, M.D., Ph.D., concluded her tenure as Chief Medical Officer.
Anna Protopapas, Anna Protopapas transitioned from President and CEO to a strategic advisor and Board member role, stepping down from the CEO position.

New Appointments:

Arvin Yang, M.D., Ph.D., Arvin Yang, M.D., Ph.D., joined Mersana Therapeutics as Executive Vice President and Chief Medical Officer.
Martin Huber, M.D., Martin Huber, M.D., was appointed President and Chief Executive Officer, succeeding Anna Protopapas.

What Technology (Tech Stack) Is Used byMersana Therapeutics?

Discover the tools Mersana Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Mersana Therapeutics Email Formats and Examples

Mersana Therapeutics typically uses a standard corporate email format. The most commonly observed pattern is the first initial of the employee's first name followed by their full last name, all before the '@mersana.com' domain.

[first_initial][last_name]@mersana.com

Format

jdoe@mersana.com

Example

85%

Success rate

What's the Latest News About Mersana Therapeutics?

Mersana Therapeutics | Investor RelationsMay 9, 2024

Mersana Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Mersana Therapeutics announced its Q1 2024 financial results, highlighting progress with its ADC candidates XMT-1660 and XMT-2056. The company reaffirmed its strategic focus on these programs following its 2023 restructuring and provided updates on clinical trial enrollment and anticipated data presentations....more

Mersana Therapeutics | Investor RelationsApril 8, 2024

Mersana Therapeutics to Present Preclinical Data on XMT-1660 at the American Association for Cancer Research (AACR) Annual Meeting 2024

Mersana announced it would present preclinical data for XMT-1660, its Dolasynthen ADC targeting B7-H4, at the AACR 2024. The data showcased XMT-1660's potential in various solid tumors, including favorable pharmacokinetics and anti-tumor activity....more

Mersana Therapeutics | Investor RelationsFebruary 28, 2024

Mersana Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

The company reported its Q4 and full-year 2023 financial results, outlining its strategic priorities focused on XMT-1660 and XMT-2056. Mersana also discussed progress in its clinical development programs following the corporate restructuring undertaken in 2023....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Mersana Therapeutics, are just a search away.